Skip to content

Philip Gerrans

8 papers in the library · 288 citations · publishing 2017-2026

Papers

Sort Most recent Most cited

A neurocognitive account of complex PTSD: self-modelling, affective dysregulation, and implications for MDMA-assisted and targeted psychotherapies.

European Journal of Psychotraumatology March 19, 2026 Philip Gerrans, Hugh McGovern, Jakob Hohwy et al.

Background: Complex post-traumatic stress disorder (C-PTSD) is a trauma-related condition characterized by pervasive disturbances in affect regulation, self-concept, and interpersonal functioning that extend beyond the symptom profile of post-traumatic stress disorder (PTSD). While neurobiological studies have implicated limbic, salience, and prefrontal systems in C-PTSD, mechanistic accounts...

Ego dissolution in psychedelic experience

Anatomy of an Avatar September 19, 2024 Philip Gerrans

Abstract Users of psychedelic drugs often report that their sense of being a self or ‘I’ distinct from the rest of the world has diminished or altogether dissolved in a phenomenon known as ego dissolution (Nour et al., 2016). This is a case of transient disintegration of the self model caused by actions of serotonin 5HT2A agonists. Psychedelic experience provides a window on the nature of self...

Anatomy of an Avatar

September 19, 2024 Philip Gerrans

Abstract The self is an avatar, a virtual entity, constructed by the brain to play the game of life. To control the organism the mind manipulates the avatar through the world. The avatar co-ordinates bodily, perceptual, sensorimotor, cognitive, and metacognitive processes in pursuit of the organism’s goals, the most basic of which is homeostatic maintenance. Other processes are layered over...

Philosophical Perspectives on Psychedelic Psychiatry

September 13, 2024 Chris Letheby, Philip Gerrans 6 citations

Abstract A recent wave of research in psychiatry and neuroscience has re-examined the properties of ‘classic’ psychedelic substances—also known as serotonergic hallucinogens—such as psilocybin, lysergic acid diethylamide (LSD), and N,N-dimethyltryptamine (DMT). Evidence to date suggests that psychedelics can be given safely in controlled conditions, at moderate to high doses, and may have...

Introduction: philosophy and psychedelic psychiatry

Philosophical Perspectives on Psychedelic Psychiatry September 13, 2024 Chris Letheby, Philip Gerrans 1 citation

Abstract The chapter undertakes three main tasks. The first is to review, briefly, the history of psychedelics in psychiatry, including the phenomenological and behavioural effects that first led to their being studied for therapeutic purposes. The second is to give an overview of recent research into the safety, efficacy, and therapeutic mechanisms of psychedelic-assisted psychotherapy. The...

The self as avatar: an active inference account of ego dissolution

Philosophical Perspectives on Psychedelic Psychiatry September 13, 2024 Philip Gerrans

Abstract Daniel Dennett famously argued that the self is a ‘centre of narrative gravity’. In fact, the self is best thought of as a centre of interoceptive gravity whose homeostatic and affective experiences are subsequently interpreted and communicated in a narrative. This idea explains feelings of persistence and unity in the normal case and changed nature of self-awareness in psychedelic...

Self unbound: ego dissolution in psychedelic experience

Neuroscience of Consciousness 2017 Chris Letheby, Philip Gerrans 280 citations

Users of psychedelic drugs often report that their sense of being a self or 'I' distinct from the rest of the world has diminished or altogether dissolved. Neuroscientific study of such 'ego dissolution' experiences offers a window onto the nature of self-awareness. We argue that ego dissolution is best explained by an account that explains self-awareness as resulting from the integrated...

MDMA-Assisted Therapy for Complex-Post-Traumatic Stress Disorder: Toward a neurocognitive account

Philip Gerrans, Hugh Mgovern, Jakob Hohwy et al. 1 citation preprint

Complex post-traumatic stress disorder (C-PTSD) is a newly recognized diagnosis that is distinguished from post-traumatic stress disorder (PTSD) through additional symptom clusters beyond re-experiencing, avoidance, and a persistent sense of threat. In addition to these core PTSD symptoms, C-PTSD is characterized by disturbances in self-organization, including affective dysregulation, negative...